Related Experiment Video
Updated: Oct 20, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Crucial Roles of microRNA-Mediated Autophagy in Urologic Malignancies
Maolei Shen1, Xin Li1, Biao Qian2
1Department of Urology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, 318000, Zhejiang, China.
Abstract:
Urologic oncologies are major public health problems worldwide. Both microRNA and autophagy, separately or concurrently, are involved in a variety of the cellular and molecular processes of multiple cancers, including urologic malignancies. In this review, we have summarized the related studies and found that microRNA-mediated autophagy acted as carcinogenic factors or suppressors in prostate cancer, kidney cancer, and bladder cancer. MiRNAs, targeted genes, and the different signaling pathways constitute a complex network that orchestrates autophagy regulation, militating the oncogenic and tumor-suppressive effects in urologic malignancies. Aberrant expression of miRNAs may induce the dysregulation of the autophagy process, resulting in tumorigenesis, progression, and resistance to anticancer therapies. Targeting specific miRNAs for autophagy modulation may present as reliable diagnostic and prognostic biomarkers or promising therapeutic strategies for urologic oncologies.
Insights
MicroRNAs (miRNAs) and autophagy play dual roles in urologic cancers like prostate, kidney, and bladder cancer. Targeting miRNAs offers potential diagnostic and therapeutic strategies for these malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Urologic oncologies represent significant global health challenges.
- MicroRNA (miRNA) and autophagy are key cellular processes implicated in various cancers, including urologic malignancies.
Purpose of the Study:
- To review and summarize the intricate relationship between miRNA-mediated autophagy and urologic cancers.
- To elucidate the dual role of miRNAs in regulating autophagy as either carcinogenic or tumor-suppressive factors.
Main Methods:
- Comprehensive literature review of studies investigating miRNA and autophagy in prostate, kidney, and bladder cancers.
- Analysis of the complex regulatory network involving miRNAs, targeted genes, and signaling pathways orchestrating autophagy.
Main Results:
- MicroRNA-mediated autophagy exhibits both oncogenic and tumor-suppressive effects in prostate, kidney, and bladder cancers.
- Aberrant miRNA expression can dysregulate autophagy, contributing to tumorigenesis, cancer progression, and therapeutic resistance.
Conclusions:
- Targeting specific miRNAs for autophagy modulation presents promising diagnostic and prognostic biomarker potential.
- Modulating miRNA-driven autophagy offers a potential therapeutic strategy for urologic oncologies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Destabilization of Microtubules
Abnormal Proliferation

